Literature DB >> 22851686

Insulin resistance and cancer: epidemiological evidence.

Manami Inoue1, Shoichiro Tsugane.   

Abstract

Epidemiological research into insulin resistance has focused on excess body weight, type 2 diabetes mellitus (DM), physical activity, and coffee consumption. These common modifiable factors have also been suggested to play a role in the process of carcinogenesis via associations with insulin resistance. Findings of systematic literature reviews and meta-analyses have generally supported an association between excess body weight and DM with an increased risk of colon cancer in males, and of liver, pancreatic, and endometrial cancers. Inverse relationships between these cancers and physical activity and coffee consumption have been shown, both of which are known to reduce the risk of DM. Interventions directed at or involving these variables should contribute to decreasing the risk of insulin resistance-associated cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22851686     DOI: 10.1530/ERC-12-0142

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  29 in total

1.  [Current treatment of type 2 diabetes].

Authors:  G Schernthaner; G-H Schernthaner
Journal:  Internist (Berl)       Date:  2012-12       Impact factor: 0.743

Review 2.  Physical Activity and Nutrition in Primary and Tertiary Prevention of Colorectal Cancer.

Authors:  Michael H Schoenberg
Journal:  Visc Med       Date:  2016-06-08

Review 3.  Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians.

Authors:  Rosella Spadi; Federica Brusa; Agostino Ponzetti; Isabella Chiappino; Nadia Birocco; Libero Ciuffreda; Maria Antonietta Satolli
Journal:  World J Clin Oncol       Date:  2016-02-10

4.  Cancer incidence attributable to inadequate physical activity in Alberta in 2012.

Authors:  Darren R Brenner; Abbey E Poirier; Anne Grundy; Farah Khandwala; Alison McFadden; Christine M Friedenreich
Journal:  CMAJ Open       Date:  2017-05-03

5.  Tryptophan depletion under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through reactive oxygen species-dependent and independent pathways.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Maria Sounidaki; Georgia Antoniadi; Christos Rountas; Vassilios Liakopoulos; Loannis Stefanidis
Journal:  Mol Cell Biochem       Date:  2017-02-04       Impact factor: 3.396

6.  Chocolate consumption and risk of diabetes mellitus in the Physicians' Health Study.

Authors:  Chisa Matsumoto; Andrew B Petrone; Howard D Sesso; J Michael Gaziano; Luc Djoussé
Journal:  Am J Clin Nutr       Date:  2014-11-26       Impact factor: 7.045

7.  Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients.

Authors:  Mustafa Sahin; Bekir Uçan; Zeynep Giniş; Oya Topaloğlu; Aşkın Güngüneş; Nujen Çolak Bozkurt; Müyesser Sayki Arslan; İlknur Öztürk Ünsal; Esra Tutal Akkaymak; Taner Demirci; Melia Karaköse; Mustafa Çalışkan; Erman Çakal; Mustafa Özbek; Tuncay Delibaşı
Journal:  Med Oncol       Date:  2013-05-05       Impact factor: 3.064

8.  Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies.

Authors:  Pengcheng Xun; Ying Wu; Qianchuan He; Ka He
Journal:  Am J Clin Nutr       Date:  2013-10-16       Impact factor: 7.045

9.  Investigating Physical Activity in the Etiology of Pancreatic Cancer: The Age at Which This Is Measured Is Important and Is Independent of Body Mass Index.

Authors:  Nurulamin M Noor; Paul J R Banim; Robert N Luben; Kay-Tee Khaw; Andrew R Hart
Journal:  Pancreas       Date:  2016-03       Impact factor: 3.327

10.  The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC).

Authors:  Chiara Mele; Marina Caputo; Maria Teresa Samà; Valentina Bullara; Maria Grazia Mauri; Flavia Prodam; Gianluca Aimaretti; Loredana Pagano; Paolo Marzullo
Journal:  Eur J Clin Nutr       Date:  2020-06-09       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.